Your browser doesn't support javascript.
loading
"COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada.
Glegg, Stephanie; McCrae, Karen; Kolla, Gillian; Touesnard, Natasha; Turnbull, Jeffrey; Brothers, Thomas D; Brar, Rupinder; Sutherland, Christy; Le Foll, Bernard; Sereda, Andrea; Goyer, Marie-Ève; Rai, Nanky; Bernstein, Scott; Fairbairn, Nadia.
Afiliação
  • Glegg S; British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z 2A9, Canada; Department of Medicine, The University of British Columbia, 2775 Laurel Street, Vancouver, BC V5Z 1M9, Canada. Electronic address: stephanie.glegg@bccsu.ubc.ca.
  • McCrae K; British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z 2A9, Canada; Department of Medicine, The University of British Columbia, 2775 Laurel Street, Vancouver, BC V5Z 1M9, Canada.
  • Kolla G; Canadian Institute for Substance Use Research, Health and Wellness Building Room 273, University of Victoria, Victoria, BC V8P 5C2, Canada.
  • Touesnard N; Canadian Association of People Who Use Drugs, 102-68 Highfield Park Drive, Dartmouth, NS B3A 1X4, Canada.
  • Turnbull J; Ottawa Inner City Health, 5 Myrand Ave, Ottawa, ON K1N 5N7, Canada.
  • Brothers TD; Department of Medicine, Dalhousie University, Suite 442 Bethune Building, 1276 South Park Street, Halifax, NS B3H 2Y9, Canada.
  • Brar R; Vancouver Coastal Health Authority, 801-601 West Broadway, Vancouver, BC V5Z 4C2, Canada; Department of Family Medicine, The University of British Columbia, 3(rd) Floor, David Strangway Building, 5950 University Boulevard, Vancouver, BC V6T 1Z3, Canada.
  • Sutherland C; Department of Medicine, The University of British Columbia, 2775 Laurel Street, Vancouver, BC V5Z 1M9, Canada; PHS Community Services Society, 350 Columbia Street, Vancouver, BC V6A 4J1 Canada.
  • Le Foll B; Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON M5S 2S1, Canada; Faculty of Medicine, Institute of Medical Science, Departments of Psychiatry, Family and Community Medicine, and Pharmacology and Toxicology, University of Tor
  • Sereda A; Schulich School of Medicine, Western University, Clinical Skills Building, London, ON V6A 5C1, Canada.
  • Goyer MÈ; Department of Family Medicine, Université de Montréal, 2900 Edouard Montpetit Boulevard, QC H3T 1J4, Canada.
  • Rai N; Temerty Faculty of Medicine, University of Toronto, 1 King's College Circle, Medical Sciences Building, Room 3157, Toronto, ON V5S 1A8, Canada.
  • Bernstein S; Canadian Drug Policy Coalition, Simon Fraser University, 2400 515 West Hastings Street, Vancouver, BC V6B 5K3, Canada.
  • Fairbairn N; British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z 2A9, Canada; Department of Medicine, The University of British Columbia, 2775 Laurel Street, Vancouver, BC V5Z 1M9, Canada.
Int J Drug Policy ; 106: 103742, 2022 08.
Article em En | MEDLINE | ID: mdl-35679695
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Redução do Dano / COVID-19 Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Redução do Dano / COVID-19 Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022